ARK Investment Management’s IceCure Medical ICCM Stock Holding History
Bought
Maintained
Sold
Other funds holding ICCM
BFM
BCM
BC
BCWM
ARK Investment Management's ICCM Position: Q1 2022 in Review
ARK Investment Management sold out of IceCure Medical (ICCM) in Q1 2022, closing a stake of 15,496 shares — an estimated $1.4M sold.
ARK Investment Management first reported a position in ICCM in Q3 2021 and held it in 2 quarters. The position peaked at $2.73M in Q3 2021. 9 funds tracked by Wall St. Rank hold ICCM as of Q1 2022.
- ARK Investment Management reported no remaining IceCure Medical position as of Q1 2022 after selling out during the quarter.
- ARK Investment Management sold 15,496 IceCure Medical shares in Q1 2022, an estimated $1.4M.
- ARK Investment Management first reported a position in IceCure Medical in Q3 2021 and held it in 2 quarters.
- ARK Investment Management's IceCure Medical position peaked at $2.73M in Q3 2021.
- 9 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2022.
Based on ARK Investment Management's 13F filing for Q1 2022, filed 19 Apr 2022.